Anyea Therapeutics Co., Ltd.

Anyea Therapeutics is a biotechnology company based in Shanghai, China, primarily focused on research and development in the field of neurodevelopmental disorders and neurological diseases. The company conducts advanced research into molecular mechanisms underlying conditions such as CDKL5 deficiency disorder. The company is actively engaged in patenting novel therapeutic approaches, including the development of modulators for proteins involved in synaptic function and neuronal excitability. Their work bridges the gap between fundamental neuroscience research and potential therapeutic interventions.